Newsbot

Should Earnings Upgrade Require Action From CareDx Stock Investors?

CareDx reported Q3 2026 revenue of US$139.36 million and net income of US$19.29 million, raised its full year revenue outlook to a range of US$520 million to US$530 million, and highlighted registry data linking AlloSure Kidney donor derived cell free DNA patterns with three year transplant outcomes. The new KOAR analysis suggests AlloSure Kidney may flag molecular graft injury before routine lab measures change, which could help CareDx deepen test utilization, while the higher full year...

China Set to Lead World in Energy Investment in 2026, CCTV Says

China is expected to invest $940 billion in energy in 2026, the most by any country, according to the Global Energy Transition Report 2026 released by the China Enterprise Reform and Development Society, China Central Television reported Sunday.

Is Hims & Hers Health (HIMS) A Bargain After Its Lilly Deal?

Eli Lilly’s new agreement with Hims & Hers Health (HIMS) puts Lilly’s obesity drugs Zepbound and Foundayo directly inside the telehealth platform, giving users streamlined access to FDA-approved GLP-1 treatments for weight loss.The Lilly partnership landed after a choppy stretch for Hims & Hers Health, with the share price jumping 8.06% over the past day but still down 11.98% over 30 days and 22.18% year to date. The three year total shareholder return of about 2.8x highlights the strength...

AI Slump Revives Asia’s Forgotten Trades From China to India

The unraveling of the AI trade after the US midterm elections is forcing investors to rethink their Asia playbook, reviving demand for out-of-favor Chinese and Indian stocks as well as companies poised to benefit from easing inflation and trade tensions.

AIM weekly movers: Allergy Therapeutics plans to leave AIM

Lower emissions fuel developer Quadrise (LON: QED) expects Valkor Technologies to pay $300,000 of the licence fee it owes in early November and the remaining $650,000 could be paid before the end of the year. This cash was expected in October. This is based on Valkor completing its fundraising. Shipment of the Multifuel Manufacturing unit […]The post AIM weekly movers: Allergy Therapeutics plans to leave AIM appeared first on UK Investor Magazine.

Aquis weekly movers: Stack BTC revises acquisition terms

Energy B (LON: NGRB) chairman David Lenigas bought 100,000 shares at 16p each and 50,000 shares at 25p each. Silvertree Partners will take over accounting and company secretary activities for the company. The share price jumped 79.8% to 29p. Astrid Intelligence (LON: ASTR), which is focused on the Bittensor decentralised AI ecosystem, says Zils will operate […]The post Aquis weekly movers: Stack BTC revises acquisition terms appeared first on UK Investor Magazine.

Claude Deleted a Law Professor’s Notes; Dropbox Had Copies

95,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity. A note on sourcing. The account of the deletion is William Baude’s, from an X post and screenshot of 5 November 2026, with his replies as quoted by Dexerto. We did not see the files or the full session. […]